DE19962470A1 - Verwendung von Chemotherapeutika - Google Patents

Verwendung von Chemotherapeutika

Info

Publication number
DE19962470A1
DE19962470A1 DE19962470A DE19962470A DE19962470A1 DE 19962470 A1 DE19962470 A1 DE 19962470A1 DE 19962470 A DE19962470 A DE 19962470A DE 19962470 A DE19962470 A DE 19962470A DE 19962470 A1 DE19962470 A1 DE 19962470A1
Authority
DE
Germany
Prior art keywords
patient
treatment
formula
tooth
free
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19962470A
Other languages
German (de)
English (en)
Inventor
Hans-Herrmann Schulz
Guenther Schlimbach
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7934136&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE19962470(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Priority to DE19962470A priority Critical patent/DE19962470A1/de
Priority to CA2717246A priority patent/CA2717246C/en
Priority to US10/168,441 priority patent/US8975275B2/en
Priority to PL387061A priority patent/PL209943B1/pl
Priority to IL15035900A priority patent/IL150359A0/xx
Priority to PT03028047T priority patent/PT1408034E/pt
Priority to PCT/EP2000/013155 priority patent/WO2001045679A2/de
Priority to AT00985241T priority patent/ATE261722T1/de
Priority to TR2004/01396T priority patent/TR200401396T4/xx
Priority to EP00985241A priority patent/EP1244434B1/de
Priority to MXPA02006248A priority patent/MXPA02006248A/es
Priority to CNB008190674A priority patent/CN100488950C/zh
Priority to DK03028047.3T priority patent/DK1408034T4/da
Priority to PL357379A priority patent/PL205148B1/pl
Priority to DK00985241T priority patent/DK1244434T3/da
Priority to AT03028047T priority patent/ATE369344T1/de
Priority to KR1020027008087A priority patent/KR100803442B1/ko
Priority to AU21716/01A priority patent/AU784496B2/en
Priority to BR0017041-0A priority patent/BR0017041A/pt
Priority to ES00985241T priority patent/ES2218264T3/es
Priority to CN2009101183278A priority patent/CN101513405B/zh
Priority to PT00985241T priority patent/PT1244434E/pt
Priority to JP2001546418A priority patent/JP5414138B2/ja
Priority to CA2395459A priority patent/CA2395459C/en
Priority to DE50005742T priority patent/DE50005742D1/de
Priority to ES03028047T priority patent/ES2291583T5/es
Priority to EP03028047A priority patent/EP1408034B2/de
Priority to DE50014553T priority patent/DE50014553D1/de
Publication of DE19962470A1 publication Critical patent/DE19962470A1/de
Priority to IL150359A priority patent/IL150359A/en
Priority to NO20023026A priority patent/NO323727B1/no
Priority to ZA200205027A priority patent/ZA200205027B/en
Priority to US11/619,823 priority patent/US20070197501A1/en
Priority to NO20071958A priority patent/NO331317B1/no
Priority to CY20071101421T priority patent/CY1106977T1/el
Priority to US12/858,527 priority patent/US20100330165A1/en
Priority to US14/294,874 priority patent/US20140287028A1/en
Priority to US14/875,053 priority patent/US20160045490A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00—Preparations for dentistry
    • A61K6/50—Preparations specially adapted for dental root treatment
    • A61K6/54—Filling; Sealing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00—Preparations for dentistry
    • A61K6/60—Preparations for dentistry comprising organic or organo-metallic additives
    • A61K6/69—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE19962470A 1999-12-22 1999-12-22 Verwendung von Chemotherapeutika Withdrawn DE19962470A1 (de)

Priority Applications (37)

Application Number Priority Date Filing Date Title
DE19962470A DE19962470A1 (de) 1999-12-22 1999-12-22 Verwendung von Chemotherapeutika
DE50014553T DE50014553D1 (de) 1999-12-22 2000-12-22 Verwendung von Chinolon- und Chinolizinon-Derivaten als Chemotherapeutika
BR0017041-0A BR0017041A (pt) 1999-12-22 2000-12-22 Emprego de quimioterápicos
ES00985241T ES2218264T3 (es) 1999-12-22 2000-12-22 Uso de quimioterapicos para el tratamiento topico.
PL387061A PL209943B1 (pl) 1999-12-22 2000-12-22 Zastosowanie moksifloksacyny stanowiącej kwas 1-cyklopropylo-6-fluoro-1,4-dihydro-8-metoksy-7-[(4aS,7aS)-oktahydro-6H-pirolo [3,4-b]pirydyn-6-ylo]-4-okso-3-chinolino-karboksylowy
IL15035900A IL150359A0 (en) 1999-12-22 2000-12-22 Use of chemotherapeutic agents
PT03028047T PT1408034E (pt) 1999-12-22 2000-12-22 Utilização de derivados de quinolona e quinolizinona como agentes quimioterapêuticos
PCT/EP2000/013155 WO2001045679A2 (de) 1999-12-22 2000-12-22 Verwendung von chemotherapeutika zur topischen behandlung
AT00985241T ATE261722T1 (de) 1999-12-22 2000-12-22 Verwendung von chemotherapeutika zur topischen behandlung
TR2004/01396T TR200401396T4 (tr) 1999-12-22 2000-12-22 Kemoterapötik maddelerin kullanımı.
EP00985241A EP1244434B1 (de) 1999-12-22 2000-12-22 Verwendung von chemotherapeutika zur topischen behandlung
PT00985241T PT1244434E (pt) 1999-12-22 2000-12-22 Utilizacao de agentes quimioterapeuticos
CNB008190674A CN100488950C (zh) 1999-12-22 2000-12-22 化疗剂的应用
DK03028047.3T DK1408034T4 (da) 1999-12-22 2000-12-22 Anvendelse af quinolon- og quinolizinon-derivater som kemoterapeutika
PL357379A PL205148B1 (pl) 1999-12-22 2000-12-22 Zastosowanie chemicznych środków leczniczych
DK00985241T DK1244434T3 (da) 1999-12-22 2000-12-22 Anvendelse af kemoterapeutiske midler til topisk behandling
AT03028047T ATE369344T1 (de) 1999-12-22 2000-12-22 Verwendung von chinolon- und chinolizinon- derivaten als chemotherapeutika
KR1020027008087A KR100803442B1 (ko) 1999-12-22 2000-12-22 화학요법제의 용도
AU21716/01A AU784496B2 (en) 1999-12-22 2000-12-22 Use of chemotherapeutic agents
CA2717246A CA2717246C (en) 1999-12-22 2000-12-22 Use of quinoline and quinolizinone derivatives as chemotherapeutic agents
CN2009101183278A CN101513405B (zh) 1999-12-22 2000-12-22 化疗剂的应用
US10/168,441 US8975275B2 (en) 1999-12-22 2000-12-22 Use of chemotherapeutic agents
MXPA02006248A MXPA02006248A (es) 1999-12-22 2000-12-22 Uso de agentes quimioterapeuticos.
JP2001546418A JP5414138B2 (ja) 1999-12-22 2000-12-22 化学療法剤の使用
CA2395459A CA2395459C (en) 1999-12-22 2000-12-22 Use of quinoline and quinolizinone derivatives as chemotherapeutic agents
DE50005742T DE50005742D1 (de) 1999-12-22 2000-12-22 Verwendung von chemotherapeutika zur topischen behandlung
ES03028047T ES2291583T5 (es) 1999-12-22 2000-12-22 Utilización de derivados de quinolona y de quinolizinona como agentes quimioterapéuticos.
EP03028047A EP1408034B2 (de) 1999-12-22 2000-12-22 Verwendung von Chinolon- und Chinolizinon-Derivaten als Chemotherapeutika
IL150359A IL150359A (en) 1999-12-22 2002-06-20 Chemotherapeutic agents
NO20023026A NO323727B1 (no) 1999-12-22 2002-06-21 Anvendelse av kjemoterapi midler
ZA200205027A ZA200205027B (en) 1999-12-22 2002-06-21 Use of chemotherapeutic agents.
US11/619,823 US20070197501A1 (en) 1999-12-22 2007-01-04 Use Of Chemotherapeutic Agents
NO20071958A NO331317B1 (no) 1999-12-22 2007-04-17 Anvendelse av moxifloxacin for fremstilling av et medikament for topisk og/eller lokal behandling av sar forarsaket av infeksjoner
CY20071101421T CY1106977T1 (el) 1999-12-22 2007-11-06 Χρησιμοποιηση παραγωγων χινολονης και χινολιζινονης σαν χημειοθεραπευτικα
US12/858,527 US20100330165A1 (en) 1999-12-22 2010-08-18 Use of chemotherapeutic agents
US14/294,874 US20140287028A1 (en) 1999-12-22 2014-06-03 Use of Chemotherapeutic Agents
US14/875,053 US20160045490A1 (en) 1999-12-22 2015-10-05 Use of chemotherapeutic agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19962470A DE19962470A1 (de) 1999-12-22 1999-12-22 Verwendung von Chemotherapeutika

Publications (1)

Publication Number Publication Date
DE19962470A1 true DE19962470A1 (de) 2001-07-12

Family

ID=7934136

Family Applications (3)

Application Number Title Priority Date Filing Date
DE19962470A Withdrawn DE19962470A1 (de) 1999-12-22 1999-12-22 Verwendung von Chemotherapeutika
DE50005742T Expired - Lifetime DE50005742D1 (de) 1999-12-22 2000-12-22 Verwendung von chemotherapeutika zur topischen behandlung
DE50014553T Expired - Lifetime DE50014553D1 (de) 1999-12-22 2000-12-22 Verwendung von Chinolon- und Chinolizinon-Derivaten als Chemotherapeutika

Family Applications After (2)

Application Number Title Priority Date Filing Date
DE50005742T Expired - Lifetime DE50005742D1 (de) 1999-12-22 2000-12-22 Verwendung von chemotherapeutika zur topischen behandlung
DE50014553T Expired - Lifetime DE50014553D1 (de) 1999-12-22 2000-12-22 Verwendung von Chinolon- und Chinolizinon-Derivaten als Chemotherapeutika

Country Status (21)

Country Link
US (5) US8975275B2 (https=)
EP (2) EP1244434B1 (https=)
JP (1) JP5414138B2 (https=)
KR (1) KR100803442B1 (https=)
CN (2) CN100488950C (https=)
AT (2) ATE261722T1 (https=)
AU (1) AU784496B2 (https=)
BR (1) BR0017041A (https=)
CA (2) CA2717246C (https=)
CY (1) CY1106977T1 (https=)
DE (3) DE19962470A1 (https=)
DK (2) DK1408034T4 (https=)
ES (2) ES2291583T5 (https=)
IL (2) IL150359A0 (https=)
MX (1) MXPA02006248A (https=)
NO (2) NO323727B1 (https=)
PL (2) PL209943B1 (https=)
PT (2) PT1408034E (https=)
TR (1) TR200401396T4 (https=)
WO (1) WO2001045679A2 (https=)
ZA (1) ZA200205027B (https=)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6740664B2 (en) 1998-09-30 2004-05-25 Alcon, Inc. Methods for treating otic and ophthalmic infections
US6509327B1 (en) 1998-09-30 2003-01-21 Alcon Manufacturing, Ltd. Compositions and methods for treating otic, ophthalmic and nasal infections
US6716830B2 (en) 1998-09-30 2004-04-06 Alcon, Inc. Ophthalmic antibiotic compositions containing moxifloxacin
DE19962470A1 (de) 1999-12-22 2001-07-12 Schulz Hans Herrmann Verwendung von Chemotherapeutika
AU2003302305A1 (en) * 2002-12-31 2004-07-22 Sachin S Bhagwat Benzoquinolizine-2-carboxylic acid-containing compositions
EP1578449A2 (en) * 2002-12-31 2005-09-28 Wockhardt Limited Compositions of benzoquinolizine carboxylic acid antibiotic drugs
JP4828405B2 (ja) 2003-02-10 2011-11-30 バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト 呼吸器官の細菌性疾患の処置
DE10337191A1 (de) * 2003-08-13 2005-03-17 Bayer Healthcare Ag Neue Verwendung von Chinolon-Antibiotika
CN100410249C (zh) * 2003-09-10 2008-08-13 杏林制药株式会社 7-(4-取代-3-环丙基氨基甲基-1-吡咯烷基)喹诺酮羧酸衍生物
US20090169585A1 (en) * 2003-10-23 2009-07-02 Resveratrol Partners, Llc Resveratrol-Containing Compositions And Their Use In Modulating Gene Product Concentration Or Activity
US20050158376A1 (en) * 2003-10-23 2005-07-21 Sardi William F. Dietary supplement and method of processing same
US7759362B2 (en) 2004-04-21 2010-07-20 Institut Of Medicinal Biotechnology Chinese Academy Of Medical Sciences Quinolonecarboxylic acid compounds, preparation methods and pharmaceutical uses thereof
CN1244582C (zh) 2004-04-21 2006-03-08 中国医学科学院医药生物技术研究所 喹诺酮羧酸类化合物及其制备方法和医药用途
WO2006134431A1 (en) * 2005-05-03 2006-12-21 Ranbaxy Laboratories Limited Formate salt of gemifloxacin
US20090306035A1 (en) * 2005-08-26 2009-12-10 Emory University Compounds and Methods for modulating the Silencing of a Polynucleotide of Interest
DE102005045145B4 (de) * 2005-09-15 2025-09-25 Schülke & Mayr GmbH Verwendung von Octenidindihydrochlorid in halbfesten Zubereitungen
EP1954307A4 (en) 2005-11-14 2009-12-02 Univ Maryland Biotech Inst ORAL VACCINES AGAINST MILZBRAND ON SALMONELLA BASE
DE102006029500A1 (de) * 2006-06-27 2008-01-03 Schulz, Hans H. Verwendung einer antimikrobiellen härtenden Alginatmasse zur topischen Behandlung von Wunden und Entzündungen in der Human-, Zahn- und Veterinärmedizin
DE102007040569A1 (de) 2007-08-28 2009-03-05 Schulz, Hans H. Verfahren zur Prophylaxe von Karies und Parodontopathien
DE102008022086A1 (de) 2008-05-05 2009-11-12 Schulz, Hans H. Zweikomponenten-Alginat
EP2409702A1 (en) * 2010-07-21 2012-01-25 Bayer Innovation GmbH Combination of siloxane and active ingredient for treating dental disorder of hard tissues
WO2013074948A1 (en) 2011-11-16 2013-05-23 Resveratrol Partners, Llc Compositions containing resveratrol and nucleotides
CN103087042B (zh) * 2012-03-09 2015-02-18 南京优科生物医药有限公司 西他沙星的盐及制药用途
US9446131B2 (en) 2013-01-31 2016-09-20 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9452173B2 (en) 2013-01-31 2016-09-27 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9433680B2 (en) * 2013-01-31 2016-09-06 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US8778365B1 (en) 2013-01-31 2014-07-15 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
ES2784307T3 (es) * 2014-01-29 2020-09-24 Vyome Therapeutics Ltd Besifloxacina para el tratamiento del acné resistente
JP6644709B2 (ja) * 2014-04-29 2020-02-12 デンツプライ シロナ インコーポレーテッド 長期間薬物送達システムによる歯内療法
SG11201907358RA (en) * 2017-02-08 2019-09-27 Hkl Medical Llc Intrasite administration and dosing methods and pharmaceuticals for use therein
BR112019025960A2 (pt) * 2017-06-16 2020-11-03 Kyorin Pharmaceutical Co., Ltd. agente terapêutico para pneumonia aspirativa, supuração pulmonar ou abcesso pulmonar
US11376216B2 (en) 2018-01-02 2022-07-05 New York University Periodontal disease therapy
KR20220080176A (ko) * 2019-10-23 2022-06-14 타이젠 바이오테크놀러지 컴퍼니 리미티드 퀴놀론 카르복실산 유도체
US20250057814A1 (en) * 2023-08-14 2025-02-20 Samer M. Ebeid Endodontic biofilm-eradication technique utilizing a dual-system intracanal medication
EP4717281A1 (de) 2024-09-30 2026-04-01 Justus-Liebig-Universität Gießen, Körperschaft des öffentlichen Rechts Antimikrobielle zubereitung

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3632222A1 (de) * 1986-09-23 1988-04-07 Bayer Ag Topisch anwendbare zubereitungen von gyrase-inhibitoren
DE3704907A1 (de) * 1987-02-17 1988-08-25 Bayer Ag Topisch anwendbare zubereitungen von gyrase-inhibitoren in kombination mit kortikosteroiden
EP0286802A2 (en) * 1987-02-26 1988-10-19 Rohto Pharmaceutical Co., Ltd. Use of ofloxacin in treating or preventing locally periodontal disease
EP0763359A1 (en) * 1995-07-14 1997-03-19 R.R.A. S.r.l. Pharmaceutical composition for topical use
WO1999050344A1 (de) * 1998-03-30 1999-10-07 Espe Dental Ag Selbstdesinfizierende kunststoffe und ihre verwendung im dentalen und dentaltechnischen bereich
US6017912A (en) * 1998-02-27 2000-01-25 Bussell; Letantia Topical fluoroquinolone antibiotics in an alcohol and acetone vehicle

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2387647A1 (fr) * 1977-04-20 1978-11-17 Spad Lab Pate de traitement endodontique pour l'obturation canalaire de dents
DE3068165D1 (en) * 1980-02-28 1984-07-19 Bbc Brown Boveri & Cie Valve with damping device for the acoustic vibrations started by the working medium itself
NO156828C (no) 1980-11-10 1987-12-02 Otsuka Pharma Co Ltd Analogifremgangsm te for fremstilling av antibakterielt virksomme benzoheterocykliske forbindelser.
JPH089597B2 (ja) * 1986-01-21 1996-01-31 杏林製薬株式会社 選択毒性に優れた８‐アルコキシキノロンカルボン酸およびその塩並びにその製造方法
US4919939A (en) * 1986-04-29 1990-04-24 Pharmetrix Corporation Periodontal disease treatment system
JPS6343668A (ja) * 1986-08-07 1988-02-24 ヘキスト・アクチエンゲゼルシヤフト 抗細菌接着フイルムおよびその製造方法
DE3635453A1 (de) 1986-08-07 1988-02-11 Hoechst Ag Antibakterielle klebefolie
JP2558107B2 (ja) 1986-12-18 1996-11-27 第一製薬株式会社 外用剤
US5563138A (en) * 1987-04-16 1996-10-08 Otsuka Pharmaceutical Company, Limited Benzoheterocyclic compounds
DE3906365A1 (de) 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
JPH0737385B2 (ja) † 1989-01-18 1995-04-26 大塚製薬株式会社 外用抗菌剤
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
US5114718A (en) 1990-09-20 1992-05-19 The Procter & Gamble Company Sustained release compositions for treating periodontol disease
US5620700A (en) * 1990-10-30 1997-04-15 Alza Corporation Injectable drug delivery system and method
FR2681863B1 (fr) 1991-09-27 1995-02-03 Rhone Dpc Europ Solution de sparfloxacine sa preparation et sel la constituant.
TW209865B (https=) 1992-01-10 1993-07-21 Bayer Ag
JP2913241B2 (ja) * 1993-01-29 1999-06-28 富山化学工業株式会社 徐放性口腔用軟膏
CA2153553A1 (en) 1994-07-13 1996-01-14 Hidekazu Suzuki Stable lipid emulsion
CA2222322A1 (en) * 1995-06-06 1996-12-12 Abbott Laboratories Quinolizinone type compounds
CN1116905C (zh) * 1995-09-14 2003-08-06 高景曦 喹诺酮杀菌消炎止血纱布
CN1155382A (zh) * 1995-11-29 1997-07-30 董重里 广谱杀菌消毒剂
EP0908181B8 (en) 1996-05-20 2009-04-15 Otsuka Pharmaceutical Co., Ltd. Remedy for rosacea
JP3378772B2 (ja) 1997-06-23 2003-02-17 松下電工株式会社 コンクリート製円筒管の製造方法
KR100219327B1 (ko) 1997-08-09 1999-09-01 이서봉 퀴놀론 카르복실산 유도체
US20020037260A1 (en) * 1997-10-16 2002-03-28 Budny John A. Compositions for treating biofilm
AR020661A1 (es) 1998-09-30 2002-05-22 Alcon Lab Inc Una composicion farmaceutica topica oftalmica, otica o nasal y el uso de la misma para la manufactura de un medicamento
CA2344050A1 (en) * 1998-09-30 2000-04-06 Alcon Laboratories, Inc. Antibiotic compositions for treatment of the eye, ear and nose
CN1072498C (zh) * 1998-11-12 2001-10-10 毛和平 一种治疗人体烧伤、烫伤的外用药
CN1072499C (zh) * 1998-12-28 2001-10-10 毛和平 一种治疗人体体表慢性溃疡的外用药
US6262071B1 (en) * 1999-06-29 2001-07-17 Smithkline Beecham Corporation Methods of use of antimicrobial compounds against pathogenic amycoplasma bacteria
DE19962470A1 (de) 1999-12-22 2001-07-12 Schulz Hans Herrmann Verwendung von Chemotherapeutika
DE10347090A1 (de) * 2003-10-10 2005-05-04 Bayer Cropscience Ag Synergistische fungizide Wirkstoffkombinationen
EP1563731A1 (en) * 2004-02-12 2005-08-17 Bayer CropScience S.A. Fungicidal composition comprising a pyridylethylbenzamide derivative and a compound capable of inhibiting the ergosterol biosynthesis
JP5271229B2 (ja) 2009-10-05 2013-08-21 大道産業株式会社 濾過システム

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3632222A1 (de) * 1986-09-23 1988-04-07 Bayer Ag Topisch anwendbare zubereitungen von gyrase-inhibitoren
DE3704907A1 (de) * 1987-02-17 1988-08-25 Bayer Ag Topisch anwendbare zubereitungen von gyrase-inhibitoren in kombination mit kortikosteroiden
EP0286802A2 (en) * 1987-02-26 1988-10-19 Rohto Pharmaceutical Co., Ltd. Use of ofloxacin in treating or preventing locally periodontal disease
EP0763359A1 (en) * 1995-07-14 1997-03-19 R.R.A. S.r.l. Pharmaceutical composition for topical use
US6017912A (en) * 1998-02-27 2000-01-25 Bussell; Letantia Topical fluoroquinolone antibiotics in an alcohol and acetone vehicle
WO1999050344A1 (de) * 1998-03-30 1999-10-07 Espe Dental Ag Selbstdesinfizierende kunststoffe und ihre verwendung im dentalen und dentaltechnischen bereich

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
Chem. Abstr. 123:350041 y *
Chem. Abstr. 125:284735 r *
Chem. Abstr. 130:144078 g *
Chem. Abstr. 131:49385 s *
Chem. Abstr. 132:339269 u *

Also Published As

Publication number Publication date
CA2717246A1 (en) 2001-06-28
CY1106977T1 (el) 2012-09-26
CA2395459A1 (en) 2001-06-28
KR20020063257A (ko) 2002-08-01
DK1408034T3 (da) 2007-12-17
TR200401396T4 (tr) 2004-08-23
EP1244434A2 (de) 2002-10-02
NO323727B1 (no) 2007-07-02
IL150359A (en) 2007-12-03
US20070197501A1 (en) 2007-08-23
NO20023026D0 (no) 2002-06-21
PL209943B1 (pl) 2011-11-30
KR100803442B1 (ko) 2008-02-13
MXPA02006248A (es) 2002-12-05
DE50014553D1 (de) 2007-09-20
US20030045544A1 (en) 2003-03-06
EP1408034B2 (de) 2011-05-25
US20140287028A1 (en) 2014-09-25
PL205148B1 (pl) 2010-03-31
CN101513405A (zh) 2009-08-26
DE50005742D1 (de) 2004-04-22
DK1408034T4 (da) 2011-08-15
IL150359A0 (en) 2002-12-01
PT1244434E (pt) 2004-08-31
EP1408034A1 (de) 2004-04-14
CA2395459C (en) 2011-11-01
WO2001045679A3 (de) 2002-07-18
US8975275B2 (en) 2015-03-10
JP5414138B2 (ja) 2014-02-12
CN101513405B (zh) 2012-07-04
US20160045490A1 (en) 2016-02-18
PL357379A1 (en) 2004-07-26
NO20071958L (no) 2002-08-20
JP2004501063A (ja) 2004-01-15
EP1408034B1 (de) 2007-08-08
ATE369344T1 (de) 2007-08-15
ATE261722T1 (de) 2004-04-15
WO2001045679A2 (de) 2001-06-28
BR0017041A (pt) 2002-10-22
NO331317B1 (no) 2011-11-21
ZA200205027B (en) 2004-03-08
ES2291583T3 (es) 2008-03-01
AU2171601A (en) 2001-07-03
ES2218264T3 (es) 2004-11-16
AU784496B2 (en) 2006-04-13
CN100488950C (zh) 2009-05-20
NO20023026L (no) 2002-08-20
US20100330165A1 (en) 2010-12-30
EP1244434B1 (de) 2004-03-17
DK1244434T3 (da) 2004-07-19
ES2291583T5 (es) 2011-09-29
PT1408034E (pt) 2007-11-15
CN1668598A (zh) 2005-09-14
CA2717246C (en) 2014-02-11

Similar Documents

Publication Publication Date Title
EP1244434B1 (de) Verwendung von chemotherapeutika zur topischen behandlung
JP2004501063A5 (https=)
AT15430U1 (de) Dentales Mittel auf Basis von Hyaluronan und Octenidindihydrochlorid
AU2005202737B2 (en) Use of chemotherapeutic agents
RU2258546C1 (ru) Способ подавления патогенной микрофлоры
DE2126204A1 (de) Lysozympraparate
KR20130043203A (ko) 치과 장애 치료용 실록산 및 활성 성분의 조합물
UA88932U (uk) Спосіб лікування генералізованого пародонтиту у стадії загострення
King Remarks on Sepsis and Its Treatment
UA108293C2 (uk) Спосіб лікування генералізованого пародонтиту у стадії загострення

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
8139 Disposal/non-payment of the annual fee